Literature DB >> 26046003

Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells.

Shadan Ali1, Raagini Suresh2, Sanjeev Banerjee2, Bin Bao2, Zhihong Xu3, Jeremy Wilson3, Philip A Philip1, Minoti Apte3, Fazlul H Sarkar4.   

Abstract

Understanding of molecular events associated with tumor microenvironment in pancreatic cancer (PC) is an active area of research especially because of the rich desmoplasia seen in human PC. Desmoplasia is contributed by several cell types including cancer-associated fibroblast (CAF) and stellate cells (PSCs), which are believed to play critical roles in conferring aggressiveness to PC. The aberrant expression of microRNAs (miRNAs) in PSCs and CAF cells appears to play a pivotal role in the development and progression of PC. In this study, expression analysis of miR-21/miR-221 in conditioned media derived from PSCs/CAF cells, and from PSCs/CAF cells showed up-regulation of both miRNAs compared to MIAPaCa-2 PC cells. In addition, miR-21 expression in stellate cells derived from normal pancreas was substantially lower when compared to PSCs or CAF cells. COLO-357 PC cells cultured in the presence of conditioned media derived from PSC/CAF cells led to a significant increase in clonogenicity and pancreatosphere formation. Furthermore, inhibition of miR-21 with antisense oligonucleotide (ASO) transfection resulted in decreased migration/invasive capacity of PSCs. Similarly, the effect of ASO-miR-221 transfection in CAF cells reduced the expression of NF-κB and K-Ras (target of miR-221) along with inhibition of migration/invasion. Moreover, miRNA expression profiling of PSCs, MIAPaCa-2, and COLO-357 cells, and further validation by real-time PCR, showed several differentially expressed miRNAs, among which four was significantly up-regulated. Collectively, these results suggest a crosstalk between PSCs/CAF cells and PC cells, resulting in the up-regulation of miR-21/miR-221 expression which in part may confer aggressiveness to PC. We conclude that targeting these miRNAs could be useful for developing precision medicine for the prevention of tumor progression and/or for the treatment of PC.

Entities:  

Keywords:  CAF cells; Stellate cells; exosomes; miRNA; pancreatic cancer

Year:  2015        PMID: 26046003      PMCID: PMC4449452     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  44 in total

Review 1.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Authors:  Shadan Ali; Aamir Ahmad; Sanjeev Banerjee; Subhash Padhye; Kristin Dominiak; Jacqueline M Schaffert; Zhiwei Wang; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

3.  Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.

Authors:  Yingjie Yu; Fazlul H Sarkar; Adhip P N Majumdar
Journal:  Transl Oncol       Date:  2013-04-01       Impact factor: 4.243

Review 4.  Pancreatic cancer: pathobiology, treatment options, and drug delivery.

Authors:  Jing Li; M Guillaume Wientjes; Jessie L-S Au
Journal:  AAPS J       Date:  2010-03-03       Impact factor: 4.009

Review 5.  Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.

Authors:  Minoti V Apte; Jeremy S Wilson
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.

Authors:  Zhengping Zhang; Yinhe Zha; Wei Hu; Zhen Huang; Zhongfei Gao; Yuhui Zang; Jiangning Chen; Lei Dong; Junfeng Zhang
Journal:  J Biol Chem       Date:  2013-11-06       Impact factor: 5.157

7.  Recruitment and activation of pancreatic stellate cells from the bone marrow in pancreatic cancer: a model of tumor-host interaction.

Authors:  Christopher J Scarlett; Emily K Colvin; Mark Pinese; David K Chang; Adrienne L Morey; Elizabeth A Musgrove; Marina Pajic; Minoti Apte; Susan M Henshall; Robert L Sutherland; James G Kench; Andrew V Biankin
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

8.  Exosomes: secreted vesicles and intercellular communications.

Authors:  Clotilde Théry
Journal:  F1000 Biol Rep       Date:  2011-07-01

9.  miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs.

Authors:  Laura Lupini; Cristian Bassi; Manuela Ferracin; Nenad Bartonicek; Lucilla D'Abundo; Barbara Zagatti; Elisa Callegari; Gentian Musa; Farzaneh Moshiri; Laura Gramantieri; Fernando J Corrales; Anton J Enright; Silvia Sabbioni; Massimo Negrini
Journal:  Front Genet       Date:  2013-04-25       Impact factor: 4.599

Review 10.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

View more
  36 in total

Review 1.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Authors:  Amir Savardashtaki; Zahra Shabaninejad; Ahmad Movahedpour; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2019-11-08       Impact factor: 4.778

2.  Exosome-Mediated Intercellular Communication Between Stellate Cells and Cancer Cells in Pancreatic Ductal Adenocarcinoma.

Authors:  Aurelia Lugea; Richard T Waldron
Journal:  Pancreas       Date:  2017-01       Impact factor: 3.327

Review 3.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

4.  Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma Development.

Authors:  Nina J Chu; Robert A Anders; Elana J Fertig; Minwei Cao; Alexander C Hopkins; Bridget P Keenan; Aleksandra Popovic; Todd D Armstrong; Elizabeth M Jaffee; Jacquelyn W Zimmerman
Journal:  Cancer Prev Res (Phila)       Date:  2020-05-14

Review 5.  The emerging roles of exosomes in tumor-stroma interaction.

Authors:  Hailong Fu; Huan Yang; Xu Zhang; Wenrong Xu
Journal:  J Cancer Res Clin Oncol       Date:  2016-03-17       Impact factor: 4.553

6.  The role of microRNAs in the modulation of cancer-associated fibroblasts activity during pancreatic cancer pathogenesis.

Authors:  Lawrence N Barrera; P Matthew Ridley; Camino Bermejo-Rodriguez; Eithne Costello; Pedro A Perez-Mancera
Journal:  J Physiol Biochem       Date:  2022-06-29       Impact factor: 4.158

7.  Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer.

Authors:  Shadan Ali; Hala Dubaybo; Randall E Brand; Fazlul H Sarkar
Journal:  J Cancer Sci Ther       Date:  2015

Review 8.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

Review 9.  The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.

Authors:  Zheng Zhao; Guiping Zhao; Shuyue Yang; Shengtao Zhu; Shutian Zhang; Peng Li
Journal:  Cancer Cell Int       Date:  2021-07-09       Impact factor: 5.722

Review 10.  Extracellular Vesicles in Organ Fibrosis: Mechanisms, Therapies, and Diagnostics.

Authors:  David R Brigstock
Journal:  Cells       Date:  2021-06-25       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.